Medindia
Advertisement

Where in the US Did You Get Your Imaging Tests for Breast, Prostate Cancer?

by Dr. Trupti Shirole on March 23, 2015 at 2:50 PM

Where in the US Did You Get Your Imaging Tests for Breast, Prostate Cancer?
Doctors often recommend medical tests such as imaging techniques to rightly diagnose a health condition. Researchers from NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center have revealed patients with low-risk prostate or breast cancer were more or less likely to receive inappropriate imaging tests during treatment, depending on the region of the country in which they received medical care.

Researchers analyzed medical records from 2004-2007 of 9,219 men with low-risk prostate cancer and 30,398 women with low-risk breast cancer, across 84 separate hospital referral regions (HRRs). They found that overuse of imaging occurred at a rate of approximately 44.4% for men and nearly 42% for women. This inappropriate use of imaging was strongly linked to certain regions across the U.S. in which patients were treated. For example, HRRs in the Northeast reported higher use of imaging techniques for low-risk patients, while other regions, such as the Northwest and Utah, demonstrated more appropriate use of imaging.
Advertisement

Danil V. Makarov, assistant professor of Urology, Population Health, and Health Policy at NYU Langone and a member of the Perlmutter Cancer Center and lead investigator of the study said, "These findings challenge us to move in a different direction than focusing exclusively on individual patient/doctor decision making. Policy makers and researchers need to target high-utilization regions and promote incentives for appropriate care. Such a focus would enhance efforts to cut excessive health spending and build value-based strategies into health care practice. If we are to achieve better value-based care, we must focus on issues such as regional culture and infrastructure. The push to focus on decision making between doctor and patient is not likely to be sufficient."

The study appears online in JAMA Oncology.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
'Hybrid Immunity' may Help Elude COVID-19 Pandemic
Stroop Effect
Plant-Based Diet may Reduce the Risk of COVID-19
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Prostate Cancer Trans-Urethral Resection of the Prostate Prostate Cancer: Treatment Options Prostate Specific Antigen [PSA] Medical Management of Prostate Cancer 

Recommended Reading
Magnetic Resonance Imaging
Encyclopedia section of medindia gives general info about Magnetic Resonance Imaging...
Does Routine Imaging in Low Back Pain - Do More Harm Than Good?
Routine imaging does not seem to improve clinical outcomes and exposes patients to unnecessary ......
Research Suggests Imaging Technology Could Unlock Mysteries of a Childhood Disease
Research indicates that most children have had respiratory syncytial virus (RSV) and have suffered ....
Medical Management of Prostate Cancer
Prostate cancer is the second most common cancer in men after skin cancer and it is the sixth leadin...
Prostate Cancer
This cancer affects men over the age of 50 years and screening with rectal examination and PSA can h...
Prostate Cancer: Treatment Options
Treatment options of prostate cancer includes waiting, surgery, radiation, hormone therapy, chemothe...
Prostate Specific Antigen [PSA]
PSA blood test is specific to prostate gland but not necessarily a cancer specific test but is commo...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use